CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris

Summary

Multi-center, open-label, non-comparative safety and efficacy study with 52 Weeks of treatment on the face and trunk for acne vulgaris.

Timeline

Start

2015-02-23

Primary completion

2017-02-23

Completion

2017-02-23

Drugs

Indications